Vision loss accelerates when you stop injections, but the timeline and severity depend on your specific condition and how long you've been treated

If you stop anti-VEGF injections (the standard treatment for wet macular degeneration), your vision will likely worsen. The disease resumes its natural progression. How fast this happens and how much sight you lose depends on whether you have wet or dry macular degeneration, how long you've been on injections, and your individual disease pattern. Some people notice changes within weeks; others over months. The key point: stopping injections does not lock in your current vision—it allows the underlying disease to advance again.

The injections themselves do not cure macular degeneration. They work by blocking a protein called VEGF that causes abnormal blood vessel growth in wet macular degeneration. Once you stop the medication, that protein returns and the vessels resume leaking fluid and blood under the retina. Your macula—the part of the eye responsible for sharp, central vision—begins to accumulate damage again.

Key Takeaways

  • Stopping injections allows wet macular degeneration to progress; vision loss typically resumes within weeks to months depending on your disease pattern.
  • The longer you have been on injections, the more stable your vision may be, but stopping still triggers disease activity to return.
  • Some people can safely extend the time between injections under their doctor's monitoring, but stopping entirely is different from spacing out doses.
  • Dry macular degeneration does not use anti-VEGF injections, so this decision applies only to wet macular degeneration.
  • If cost, side effects, or access are the reason you are considering stopping, your eye doctor can discuss alternatives or modified treatment schedules.

Why vision loss resumes after you stop injections

Anti-VEGF injections work only while the medication is in your eye. The drug does not repair damage that has already happened to your retina. It prevents new damage by stopping the growth of leaky blood vessels. Once you stop receiving injections, the VEGF protein builds up again and the abnormal vessels resume their activity.

The disease itself has not been cured or put into permanent remission. You are managing an ongoing condition. Think of it like blood pressure medication: stopping it does not mean your blood pressure stays controlled. The underlying condition returns.

How quickly vision loss happens after stopping treatment

There is no single timeline. Some people experience noticeable vision loss within 4 to 8 weeks of stopping injections. Others may have a slower decline over several months. A few people with very stable disease on long-term treatment may have a slower initial response, but vision loss does eventually resume.

Your eye doctor can tell you more about your own risk based on how your disease has behaved while you were on treatment. If your vision was stable on a regular injection schedule, stopping that schedule will likely trigger disease activity. If you were already on extended intervals between injections (such as every 8 or 12 weeks instead of every 4), stopping entirely is a bigger change than spacing doses further apart.

The difference between stopping injections and spacing them out

Some people on long-term anti-VEGF treatment can safely extend the time between injections—moving from monthly to every 6 weeks, for example—while their eye doctor monitors their vision and retinal imaging. This is called treat-and-extend dosing, and it is a planned strategy to reduce the number of injections while maintaining vision.

Stopping injections entirely is not the same as extending the interval. If you are considering reducing the frequency of treatment, talk to your eye doctor about whether a modified schedule is safe for you. Do not stop on your own without medical guidance. Your doctor needs to monitor your retina with imaging (optical coherence tomography, or OCT) to know whether extended intervals are working for your specific disease.

What happens to the retina after you stop

Fluid and blood accumulate again under the retina. Your OCT imaging—the detailed cross-section scan your eye doctor uses to see the retina—will show this fluid returning. The macula swells. Scar tissue may form if the disease is left untreated for a long time. This scarring is permanent and cannot be reversed, even if you restart injections later.

The longer you go without treatment, the greater the risk of permanent damage. This is why stopping injections is not a neutral decision. It is a choice to allow a progressive disease to progress.

Restarting injections after you have stopped

If you stop injections and then restart them weeks or months later, your vision may not return to where it was before you stopped. The disease will have advanced. Restarting treatment can halt further loss and sometimes stabilize vision, but it cannot undo damage that occurred while you were off treatment.

This is especially true if scarring has developed. Scarring in the macula is permanent. If you are thinking about stopping treatment temporarily, understand that you may not get back to your baseline vision. Your eye doctor can discuss the specific risks for your disease and how long you can safely wait if you need a break.

Reasons people consider stopping and what to discuss with your doctor

The most common reasons are cost (even with insurance, copays add up), the burden of frequent office visits, side effects like floaters or eye irritation, or simply the difficulty of maintaining a strict injection schedule. These are real obstacles, and your eye doctor should know about them.

If cost is the issue, ask about patient assistance programs from the drug manufacturers (Regeneron, Roche, and Allergan all offer them). If the schedule is too demanding, ask whether your disease is stable enough to move to extended intervals. If you are experiencing side effects, your doctor may be able to switch you to a different anti-VEGF drug or adjust the injection technique. If you are struggling with the emotional or physical burden of treatment, that is worth discussing too—your doctor may have resources or referrals.

Do not stop injections without talking to your eye doctor first. Even if you decide to stop, having that conversation means your doctor can monitor your retina closely and catch disease progression early if you change your mind.

Frequently Asked Questions

Can I stop injections if my vision has been stable for a long time?

Stability on injections does not mean the disease is cured. It means the medication is working. If you stop, the disease will resume activity. Your doctor may be able to extend the time between injections if your disease is very stable, but that is different from stopping entirely. Ask your doctor whether extended intervals are an option for you.

Will my vision come back if I restart injections after stopping?

Restarting treatment can stop further loss and sometimes stabilize vision, but it cannot restore vision you lost while off treatment. The longer you are off injections, the more permanent damage may occur. If you are considering a break, discuss the timeline and risks with your eye doctor first.

What if I miss a few injections by accident?

Missing one or two injections is not the same as stopping treatment. Contact your eye doctor to reschedule as soon as possible. If you are having trouble keeping appointments, tell your doctor—they may be able to adjust your schedule or connect you with resources to help you get to visits.

Does dry macular degeneration require injections?

No. Anti-VEGF injections are used only for wet macular degeneration. Dry macular degeneration is managed with vitamins, lifestyle changes, and monitoring. If you have dry macular degeneration, this decision does not apply to you.

What if I cannot afford the injections?

Talk to your eye doctor about cost. Regeneron (Eylea), Roche (Avastin), and Allergan (Lucentis) all have patient assistance programs that may reduce or eliminate your out-of-pocket cost. Your doctor's office may also know about local resources or clinical trials. Do not stop treatment without exploring these options first.